Ideal Therapeutics will be attending the Nebraska Hospital Association Spring Forum on May 25th. #NHASF2017 #NHAspringforum
Ideal Therapeutics President and CEO, Casey Nelson is presenting “Strategies to Optimize 340B Opportunities” on Monday April 10th at the IDN Summit and Reverse Expo in Orlando, Florida.
Ideal Therapeutics is proud to announce that COO Dave Hanson has become one of the first to earn the Apexus LLC Advanced 340B Operations Certificate. Congratulations to Dave!!
Ideal Therapeutics is attending the 13th Annual 340B Coalition Conference in San Francisco, CA from January 31 – February 3, 2017. We look forward to meeting with you!